SEC Form 4 · accession 0001104659-17-043016
SYNERGY PHARMACEUTICALS, INC. · SGYP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard J Daly
Director
Period of report
Jun 28, 2017
Accepted (ET)
Jun 30, 2017 · 5:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001347613
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $4.50 | Jun 28, 2017 | A | 62,500 | A | Jun 28, 2018 | Jun 28, 2027 | Common Stock | 62,500 | 189,056 | D |